MedTrace Logo

Watermelon Dose Response Blood Pressure Study

NCT05892328 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-05-08

No results posted yet for this study

Summary

1. Primary outcome: To evaluate the dose response effects of watermelon flesh in regulating Blood Pressure (BP) in individuals with pre-hypertension.
2. Secondary outcomes: To study the dose-response effects of watermelon flesh intake on cardio-metabolic risk factors including plasma metabolic markers, lipid profile and nitrate/nitrite levels in individuals with pre-hypertension.

Conditions

Interventions

OTHER

Watermelon Flesh Dose 1

1 cup watermelon flesh, \~152g, 7 days/week over a 4-week period

OTHER

Watermelon Flesh Dose 2

2 cups watermelon flesh, \~304 g, 7 days/week over a 4-week period

OTHER

Control

304g italian ice, 0 g watermelon, 7 days/week over a 4-week period

Sponsors & Collaborators

  • National Watermelon Promotion Board

    collaborator OTHER

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Indika Edirisinghe, Ph.D. · Illinois Institute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-07
Primary Completion
2023-12-01
Completion
2026-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05892328 on ClinicalTrials.gov